ConductScience.org, home

Library / Genes

CD47: CD47 molecule

1 protein, 335 patents, 2 drugs, 47 trials, 5,006 NIH grants and 10,844 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCD47HGNC
NameCD47 moleculeHGNC
NCBI Gene ID961NCBI Gene
HGNC IDHGNC:1682HGNC
EnsemblENSG00000196776NCBI Gene
AliasesIAP, MER6, OA3NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q08722Leukocyte surface antigen CD4732315Ensembl, GeneID, HGNCUniProt

Patents 335

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4808571 A12026-09-238Q08722Espacenet
EP 4801975 A12026-09-0927Q08722Espacenet
JP 2026529293 A2026-08-282Q08722Espacenet
JP 2026529293 A2026-08-28199Q08722Espacenet
WO 2026171881 A12026-08-2019Q08722Espacenet
JP 2026515949 A2026-05-192Q08722Espacenet
JP 2026515949 A2026-05-1978Q08722Espacenet
JP 2026515163 A2026-05-147Q08722Espacenet
WO 2026027944 A12026-02-0542Q08722Espacenet
JP 2026503880 A2026-02-0214Q08722Espacenet

Drugs 2

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
EVORPACEPTCHEMBL4297880Leukocyte surface antigen CD47 inhibitorINHIBITORChEMBL
MAGROLIMABCHEMBL4297985Leukocyte surface antigen CD47 inhibitorINHIBITORChEMBL

Trials 47

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07007559EVORPACEPTPHASE2ClinicalTrials.gov
NCT06046482MAGROLIMABPHASE22025-10-22ClinicalTrials.gov
NCT05929716MAGROLIMABPHASE2ClinicalTrials.gov
NCT05868226EVORPACEPTPHASE1ClinicalTrials.gov
NCT05835011MAGROLIMABPHASE22024-10-02ClinicalTrials.gov
NCT05829434MAGROLIMABPHASE2ClinicalTrials.gov
NCT05823480MAGROLIMABPHASE1ClinicalTrials.gov
NCT05807126MAGROLIMABPHASE1ClinicalTrials.gov
NCT05738161MAGROLIMABPHASE1ClinicalTrials.gov
NCT05627466MAGROLIMABClinicalTrials.gov

NIH grants 5006

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant672,025NIH's project files
P30CA016672Cancer Center Support Grant522,025NIH's project files
P01AI045897A Tolerance Approach to Xenotransplantation322,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award192,025NIH's project files
P30CA124435Stanford Cancer Institute182,025NIH's project files
T32CA009302Leveraging innovative technologies in basic and clinical cancer research182,025NIH's project files
T32AI007290Molecular and Cellular Immunobiology172,025NIH's project files
P30CA006973Regional Oncology Research Center162,025NIH's project files
R01DK079392Intestinal Inflammation: Signaling proteins and the rate of PMN transmigration142,025NIH's project files
P30CA033572Cancer Center Support Grant132,025NIH's project files

Papers 10844

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42827453PubTator, text miningPubMed
42826145PubTator, text miningPubMed
42818334PubTator, text miningPubMed
42816832PubTator, text miningPubMed
42813858PubTator, text miningPubMed
42808109PubTator, text miningPubMed
42805968PubTator, text miningPubMed
42804006PubTator, text miningPubMed
42801636PubTator, text miningPubMed
42798844PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license